Literature DB >> 19728130

Effect of induced pyrexia on the disposition kinetics of ciprofloxacin in dogs.

Faqir Muhammad1, Masood Akhtar, M Irfan Anwar, M Javed Arshed.   

Abstract

Ciprofloxacin was administered intravenously @5 mg/kg body weight to six healthy dogs. After a washout period of two weeks, fever was induced by injecting Escherichia (E) coli endotoxin. Ciprofloxacin was administered again. Blood samples were collected at various time intervals and analyzed for ciprofloxacin with HPLC. The kinetic analysis revealed the volume of distribution in healthy vs. febrile dogs as 2.12 +/- 0.32 vs. 1.79 +/- 0.43 L/Kg, respectively. The elimination half life was 2.23 +/- 0.78 and 2.07 +/- 0.74 hours in healthy and febrile dogs, respectively. Similarly, dogs under healthy and febrile conditions showed comparable total plasma clearance of 0.66 +/- 0.06 and 0.60 +/- 0.07 L/Kg/h, respectively. All these and other investigated kinetic parameters were statistically non significant. This study concludes that the pharmacokinetic behavior of ciprofloxacin is similar under healthy and febrile conditions. Thus, the kinetic studies of fluoroquinolones conducted in normal/healthy animals may be used to depict the pharmacokinetic parameters in diseased animals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728130     DOI: 10.1007/s11259-009-9315-3

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  19 in total

1.  Disposition kinetics of erythromycin in normal and experimentally-induced febrile rabbits.

Authors:  M Ahmad; T Ahmad; N I Bukhari
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Apr-Jun       Impact factor: 2.441

2.  Influence of Escherichia coli endotoxin-induced fever on the pharmacokinetic behavior of marbofloxacin after intravenous administration in goats.

Authors:  S Waxman; M D San Andrés; F González; J J De Lucas; M I San Andrés; C Rodríguez
Journal:  J Vet Pharmacol Ther       Date:  2003-02       Impact factor: 1.786

3.  Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase.

Authors:  F L Alovero; X S Pan; J E Morris; R H Manzo; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 4.  DNA gyrase, topoisomerase IV, and the 4-quinolones.

Authors:  K Drlica; X Zhao
Journal:  Microbiol Mol Biol Rev       Date:  1997-09       Impact factor: 11.056

5.  The effect of induced fever on the biokinetics of norfloxacin and its interaction with probenecid in goats.

Authors:  K Jha; B K Roy; R C Singh
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

Review 6.  Effects of bacterial endotoxin on drug pharmacokinetics.

Authors:  T Hasegawa; K Takagi; K Kitaichi
Journal:  Nagoya J Med Sci       Date:  1999-05       Impact factor: 1.131

7.  Influence of induced disease states on the disposition kinetics of imidocarb in goats.

Authors:  A Salam Abdullah; J D Baggot
Journal:  J Vet Pharmacol Ther       Date:  1986-06       Impact factor: 1.786

8.  Disposition of ciprofloxacin following intravenous administration in dogs.

Authors:  A R Abadía; J J Aramayona; M J Muñoz; J M Pla Delfina; M P Saez; M A Bregante
Journal:  J Vet Pharmacol Ther       Date:  1994-10       Impact factor: 1.786

9.  Ciprofloxacin pharmacokinetics in dogs following oral administration.

Authors:  A R Abadia; J J Aramayona; M J Muñoz; J M Pla Delfina; M A Bregante
Journal:  Zentralbl Veterinarmed A       Date:  1995-10

10.  The hepatic and duodenal activities of some drug metabolizing enzymes in chickens: influence of infection with Escherichia coli endotoxin and coccidiosis.

Authors:  B H Ali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jul-Sep       Impact factor: 2.569

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.